November 20th, 2020 | 11:20 CET
BioNTech, Saturn Oil & Gas, Moderna - these stocks will explode!
Now it's all happening at once with the news in the race against the Corona pandemic. According to BioNTech and its US competitor Moderna, first deliveries of the vaccine are scheduled for the end of this year and the start of 2021. The first step towards normality, even though the head of BioNTech, Ugur Sahin, does not expect a normal social life until the end of 2021 at the earliest. Then, if everything goes smoothly, badly shaken industries should experience an unprecedented renaissance, and their share prices should take off.
time to read: 2 minutes
|
Author:
Stefan Feulner
ISIN:
CA80412L1076 , US09075V1026 , US60770K1079
Table of contents:
Author
Stefan Feulner
The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.
Tag cloud
Shares cloud
Oil in a deep sleep
The economy in partial lockdown, planes on the ground and hotels closed. The rapid economic downturn has shaken the oil industry to its core. Traces of the downturn can be seen on the chart of Brent oil. 1 barrel cost almost USD 68.00 in October 2019 and then came Corona. At the low point, the price was USD 27.00 but is currently stabilizing at just under USD 42.00. The reason for the stabilization is the imminent prospect of quickly approved vaccines.
Analysts optimistic
According to the analysts, the turnaround is imminent. Citigroup's experts assume that the global oil demand will reach the pre-Corona level by the end of 2021. At Fitch Solutions, too, the situation remains relaxed. It confirmed its forecast for the price of Brent oil through 2024 at the end of October. Analysts expect Brent to cost an average of USD 44.0 per barrel in 2020, USD 51.0 per barrel in 2021, USD 53.0 per barrel in 2022, USD 55.0 per barrel in 2023 and USD 58.0 per barrel in 2024.
Cheapest oil producer in Canada
In comparison to industry giants such as Exxon Mobil, Shell, BP, who all quote production costs of more than USD 30 per barrel, the Canadian oil producer Saturn Oil & Gas pays only a measly USD 12 per barrel. These low costs made the Calgary-based Company by far the cheapest oil producer in Canada in 2019.
Falling prices as an opportunity
If the CEO of Saturn Oil & Gas John Jeffrey has his way, production costs are to be kept within this range. Since own drilling programs tend to be more complex and expensive, the management's strategy is based on inorganic growth, i.e. the acquisition of exciting competitors that have an attractive risk/reward profile due to the crisis. The ambitious goal of Saturn Oil & Gas is to become an innovation leader in the oil and gas industry.
Management trimmed for growth
In addition to the appointment of the experienced Wendy Woolsey as interim CFO, the management of Saturn Oil & Gas has achieved another coup. Jean-Pierre Colin joins the team as the senior strategy consultant. Colin is regarded in the industry as one of the great minds due to his incredibly successful career. Among other things, Colin has advised several high-ranking politicians in the Canadian federal government and the Privy Council of Canada on five acquisitions of the country's largest oil and gas companies in the 1980s by Petro-Canada. Colin also served on the boards of many successful junior commodities companies, including Pelangio Mines Inc. and Virginia Gold Inc. which sold its Eleonor project for more than $1 billion to Goldcorp Inc., now known as Newmont Corporation.
Clear objectives
The newcomer was relatively clear about its objectives: "Saturn Oil & Gas represents a unique opportunity to build an acquisition vehicle for oil and gas that offers inorganic growth opportunities and returns for its shareholders and other key stakeholders". The current market capitalization of Saturn Oil & Gas is just under EUR 15 million. It is probably only a matter of time before the first success stories are reported on the tickers. Since the last announcement, there has been a noticeable increase in trading volume at ever-higher prices. The share price on the TSXV is currently CAD 0.12. A sustained break-out through the resistance at CAD 0.14 should result in significantly higher prices.
Conflict of interest
Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.
Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.
Risk notice
Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.
The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.
The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.
